RMD - Latest News
ResMed Inc. (RMD), operates in Healthcare / Medical - Instruments & Supplies, trades on NYSE.
Market capitalization stands near $32.07B. Trailing twelve-month P/E ratio is 21.00. Beta to the broader market is 0.77.
The article list below shows the most recent RMD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent RMD Headlines
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
defenseworld.net - Sep 22, 2026
ResMed (NYSE: RMD) outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing de
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
marketbeat.com - Sep 21, 2026
ResMed NYSE: RMD outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing dema
Engineers Gate Manager LP Has $1.58 Million Stake in ResMed Inc. $RMD
defenseworld.net - Sep 17, 2026
Engineers Gate Manager LP raised its stake in ResMed Inc. (NYSE: RMD) by 77.
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
barrons.com - Sep 15, 2026
Setbacks for competitors have positioned ResMed to capture more market share.
Wall Street Lunch: AI Regulation Hopes Fade After Trump Calls AI Concerns A 'Hoax'
seekingalpha.com - Sep 15, 2026
AI regulation odds have sharply declined after Trump dismissed AI takeover concerns during a public call with Nvidia (NVDA) CEO Jensen Huang. ResMed
How News Affects RMD Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track RMD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked RMD news questions
- What is the latest RMD news headline?
- The most recent RMD headline (Sep 22, 2026) is "ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the RMD news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What RMD news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual RMD options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.